M&A Will Accelerate In European Markets, Slow Down In U.S. – Schering CEO
This article was originally published in The Tan Sheet
Executive Summary
The Rx drug industry can expect to see much more merger activity among European companies, while consolidation in the U.S. essentially has tapered off, Schering-Plough CEO Fred Hassan said